CarGurus (NASDAQ:CARG) Azioni

CARGURUS INC

CarGurus

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

Scotiabank analyst Andrew Weisel maintains American Electric Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) with a Sector Perform and raises the price target from $102 to $114.

News

Price Target

Analyst Ratings

Scotiabank Maintains Sector Perform on American Electric Power, Raises Price Target to $114

Wolfe Research analyst Myles Walton upgrades Embraer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ERJ#NYSE">ERJ</a>) from Peer Perform to Outperform.

Upgrades

Embraer-Empresa Brasileira De Aeronautica

Wolfe Research Upgrades Embraer to Outperform

<a href="https://truthsocial.com/@realDonaldTrump/114949063846293148">https://truthsocial.com/@realDonaldTrump/114949063846293148</a>

General

President Trump Posts Letter To Novo Nordisk On Truth Social

WIIM

ITRI

Itron shares are trading lower after the company reported a Q2 sales miss, issued Q3 sales guidance below estimates, and cut its FY25 sales guidance.

Scotiabank analyst George Farmer maintains Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) with a Sector Outperform and raises the price target from $93 to $133.

ACLX

Scotiabank Maintains Sector Outperform on Arcellx, Raises Price Target to $133

<a href="https://truthsocial.com/@realDonaldTrump/114949062024340246">https://truthsocial.com/@realDonaldTrump/114949062024340246</a>

President Trump Posts Letter To AstraZeneca On Truth Social

AGCO Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) announced its <a href="https://www.benzinga.com/pressreleases/25/07/n46752468/agco-reports-second-quarter-results" target="_blank" rel="noopener">second-quarter</a> financial results on Thursday, which surpassed analyst expectations. The results were driven by disciplined execution in a challenging agricultural market.
AGCO is challenging its highest level of the year. <a href="https://www.benzinga.com/quote/AGCO" target="_blank" rel="noreferrer noopener">See real-time price here.</a>
AGCO&#8217;s shares traded higher following the announcement, as the company also raised its full-year 2025 guidance for both adjusted EPS and net sales.
The global leader in agricultural machinery and precision technology reported adjusted earnings per share of $1.35, significantly beating the consensus estimate of $1.07. Net sales for the quarter were $2.63 billion, down 18.8% year over year but above the $2.50 billion analyst estimate.
The sales decline largely reflects the divestiture of the majority of AGCO&#8217;s Grain &amp; Protein business in the fourth quarter of 2024. Excluding the impact of the divestiture and a favorable foreign currency translation of 3.5%, comparable net sales were down 22.3% YoY.
Reported earnings per share for the quarter were $4.22, a notable improvement from a reported net loss of $(4.92) per share in the second quarter of 2024.
Also Read: <a href="http://AGCO Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) on Thursday announced its second-quarter financial results, which surpassed analyst expectations. The results were driven by disciplined execution in a challenging agricultural market. AGCO's shares traded higher following the announcement, as the company also raised its full-year 2025 guidance for both adjusted EPS and net sales. The global leader in agricultural machinery and precision technology reported adjusted earnings per share of $1.35, significantly beating the consensus estimate of $1.07. Net sales for the quarter were $2.63 billion, down 18.8% year over year but above the $2.50 billion analyst estimate. The sales decline largely reflects the divestiture of the majority of AGCO's Grain &amp; Protein business in the fourth quarter of 2024. Excluding the impact of the divestiture and a favorable foreign currency translation of 3.5%, comparable net sales were down 22.3% YoY. Reported earnings per share for the quarter were $4.22, a notable improvement from a reported net loss of $(4.92) per share in the second quarter of 2024. Also Read: These 2025 Outperformers Just Unlocked Buyback Fuel &quot;AGCO achieved solid second-quarter results with deliberate execution in the areas we can control despite a challenging global agricultural environment marked by weak farm economics and delayed purchasing decisions in several parts of the world,&quot; said Eric Hansotia, AGCO's chairman, president and CEO. &quot;Our strong earnings and cash flow generation illustrate meaningful progress in reducing dealer and company inventories through aggressive production cuts. Operating margins benefited from disciplined cost control and continued implementation of our restructuring initiatives. Demand for our premium brands remains resilient, supported by growing interest in precision agriculture and sustainable technologies,&quot; added Hansotia. The company reported a 6.2% operating margin for the quarter, a significant improvement from the negative 7.4% in the same period last year. Adjusted operating margin was 8.3% down from 10.3% a year ago. Regionally, North American net sales, excluding currency impacts, fell 32.2% due to softer industry sales and efforts to manage inventory, particularly impacting high-horsepower tractors, sprayers, and hay equipment. The North American operating margin was negative 5.3%. In Europe/Middle East (EME), net sales declined 11.2% excluding currency translation, with lower sales in most Western European markets partially offset by growth in Eastern Europe and Scandinavia. EME's operating margin was 14.7%. South American net sales, excluding currency impacts, decreased 4.7% due to dealer inventory de-stocking, but the region achieved a robust operating margin of 7.8% from improved product mix and factory efficiency. Net sales in Asia/Pacific/Africa (APA) decreased 5.9%, excluding favorable currency translation impacts, driven by weaker demand and lower production volumes, resulting in an APA operating margin of 6.9%. Year-to-date free cash flow generation has been strong, totaling $63 million through June 2025. This compares favorably to cash used in operating activities of $370 million a year ago, primarily due to effective working capital management. Hansotia noted the increasing complexity of the global trade landscape, which continues to impact farmer confidence, particularly in North America and Europe. He highlighted a growing interest in precision agriculture tools that offer efficiency gains without significant capital investment, signaling a shift in farmer purchasing priorities. Outlook Raised: The company now expects adjusted EPS to be between $4.75 and $5.00, up from the previous range of $4.00-$4.50, and above the $4.21 analyst estimate. Full-year net sales are now projected to be approximately $9.80 billion, an increase from the prior $9.60 billion outlook and higher than the $9.617 billion consensus. Price Action: AGCO shares are trading higher by 10.68% at $118.02 at the last check on Thursday. Read Next: Air Products Trims Earnings Outlook On Portfolio Optimization And Project Exits">These 2025 Outperformers Just Unlocked Buyback Fuel
&#8220;AGCO achieved solid second-quarter results with deliberate execution in the areas we can control despite a challenging global agricultural environment marked by weak farm economics and delayed purchasing decisions in several parts of the world,&#8221; said Eric Hansotia, AGCO&#8217;s chairman, president and CEO.
&#8220;Our strong earnings and cash flow generation illustrate meaningful progress in reducing dealer and company inventories through aggressive production cuts. Operating margins benefited from disciplined cost control and continued implementation of our restructuring initiatives. Demand for our premium brands remains resilient, supported by growing interest in precision agriculture and sustainable technologies,&#8221; added Hansotia.
The company reported a 6.2% operating margin for the quarter, a significant improvement from the negative 7.4% in the same period last year. Adjusted operating margin was 8.3% down from 10.3% a year ago.
Regionally, North American net sales, excluding currency impacts, fell 32.2% due to softer industry sales and efforts to manage inventory, particularly impacting high-horsepower tractors, sprayers, and hay equipment. The North American operating margin was negative 5.3%.
In Europe/Middle East (EME), net sales declined 11.2% excluding currency translation, with lower sales in most Western European markets partially offset by growth in Eastern Europe and Scandinavia. EME&#8217;s operating margin was 14.7%.
South American net sales, excluding currency impacts, decreased 4.7% due to dealer inventory de-stocking, but the region achieved a robust operating margin of 7.8% from improved product mix and factory efficiency.
Net sales in Asia/Pacific/Africa (APA) decreased 5.9%, excluding favorable currency translation impacts, driven by weaker demand and lower production volumes, resulting in an APA operating margin of 6.9%.
Year-to-date free cash flow generation has been strong, totaling $63 million through June 2025. This compares favorably to cash used in operating activities of $370 million a year ago, primarily due to effective working capital management.
Hansotia noted the increasing complexity of the global trade landscape, which continues to impact farmer confidence, particularly in North America and Europe. He highlighted a growing interest in precision agriculture tools that offer efficiency gains without significant capital investment, signaling a shift in farmer purchasing priorities.
Outlook Raised: The company now expects adjusted EPS to be between $4.75 and $5, up from the previous range of $4-$4.50, and above the $4.21 analyst estimate.
Full-year net sales are now projected to be approximately $9.80 billion, an increase from the prior $9.60 billion outlook and higher than the $9.617 billion consensus.
AGCO Price Action: AGCO shares were trading higher by 10.65% at $117.99 at publication on Thursday. 
Read Next: • <a href="https://www.benzinga.com/markets/earnings/25/07/46766113/air-products-trims-earnings-outlook-on-portfolio-optimization-and-project-exits" target="_blank" rel="noreferrer noopener">Air Products Trims Earnings Outlook On Portfolio Optimization And Project Exits</a>
Photo: Courtesy Agco

Earnings

Guidance

Movers

AGCO

Why AGCO Stock Is Surging After Q2 Results

<a href="https://truthsocial.com/@realDonaldTrump/114949059166743406">https://truthsocial.com/@realDonaldTrump/114949059166743406</a>

AMGN

President Trump Posts Letter To Amgen On Truth Social

Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) reported better-than-expected earnings for the <a href="https://www.benzinga.com/quote/SFM/earnings">second quarter on Wednesday.</a>
The company posted quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.23 per share. The company reported quarterly sales of $2.22 billion which beat the analyst consensus estimate of $2.17 billion.
Sprouts Farmers Market raised its FY2025 adjusted EPS guidance from $4.94-$5.10 to $5.20-$5.32 and also increased its FY2025 sales guidance from $8.64 billion-$8.80 billion to $8.84 billion-$8.95 billion.
&#8220;We are pleased with our excellent results for the second quarter,&#8221; said Jack Sinclair, chief executive officer of Sprouts Farmers Market. &#8220;Our dedicated team members have consistently focused on understanding and meeting the needs of our target customers. Our investments in operations, self-distribution, customer personalization, and team member development all set the stage for exciting future growth.&#8221;
Sprouts Farmers Market shares fell 3.7% to trade at $152.26 on Thursday.
These analysts made changes to their price targets on Sprouts Farmers Market following earnings announcement.
<ul class="wp-block-list">
<li>UBS analyst Mark Carden maintained Sprouts Farmers Market with a Neutral and lowered the price target from $182 to $180.</li>
<li>RBC Capital analyst Steven Shemesh maintained the stock with a Sector Perform and raised the price target from $173 to $176.</li>
</ul>
Considering buying SFM stock? Here&#8217;s what analysts think:
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46756402/top-2-risk-off-stocks-that-may-keep-you-up-at-night-this-month">Top 2 Risk Off Stocks That May Keep You Up At Night This Month</a></li>
</ul>
Photo via Shutterstock

Trading Ideas

These Analysts Revise Their Forecasts On Sprouts Farmers Market Following Q2 Results

<a href="https://truthsocial.com/@realDonaldTrump/114949058048660778">https://truthsocial.com/@realDonaldTrump/114949058048660778</a>

President Trump Posts Letter To Johnson & Johnson On Truth Social

<a href="https://www.youtube.com/watch?v=420jvl6UM9c">https://www.youtube.com/watch?v=420jvl6UM9c</a>

Macro Notification

White House Says Countries That Haven't Heard From Us Will Hear By Executive Order Or Letter By Tonight On Tariffs

XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/g46751064/xpo-reports-second-quarter-2025-results" rel="noreferrer noopener">second-quarter 2025</a> financial results on Thursday. Adjusted diluted earnings per share (EPS) of $1.05 exceeded the analyst consensus of $1.00.
Revenue reached $2.08 billion for the quarter, surpassing estimates of $2.06 billion and remaining flat year over year. XPO&#8217;s operating income for the second quarter of 2025 rose slightly to $198 million from $197 million in the same period last year.
On an adjusted basis, adjusted net income was $125 million for the quarter, compared to $135 million in the second quarter of 2024. Adjusted EBITDA for the second quarter was $340 million, a slight dip from $343 million in the prior year.
Also Read: <a href="https://www.benzinga.com/markets/earnings/25/07/46727223/old-dominion-freight-line-ceo-remains-confident-in-long-term-growth-despite-downturn" target="_blank" rel="noreferrer noopener">Old Dominion Freight Line CEO Remains Confident In Long-Term Growth Despite Downturn</a>
XPO&#8217;s North American Less-Than-Truckload (LTL) segment demonstrated strong operational performance. LTL revenue was $1.24 billion, a 2.5% decrease from the second quarter of 2024, attributed to a 5.1% decline in shipments per day and a 6.7% drop in daily tonnage.
LTL segment achieved an adjusted operating ratio of 82.9%, a 30-basis-point improvement year-over-year, which CEO Mario Harik called &#8220;industry-best.&#8221; Yield, excluding fuel, increased by 6.1%, and revenue per shipment grew by 5.6%. 
The company also significantly reduced purchased transportation expenses by 53% through insourcing linehaul miles. Adjusted EBITDA for the North American LTL segment increased 1.0% to $300 million.
The European Transportation segment reported revenue of $841 million, up 4.1% year-over-year. However, adjusted EBITDA for this segment declined to $44 million from $49 million in the prior year.
Net income for the quarter was $106 million, down from $150 million a year ago. This decline in diluted EPS to $0.89 from $1.25 in the prior-year period was largely due to XPO lapping a one-time tax benefit related to its European business a year ago.
XPO generated $247 million in operating cash flow and ended the quarter with $225 million in cash and cash equivalents.
&#8220;In our North American LTL business, we achieved an adjusted operating ratio of 82.9%, reflecting an industry-best year-over-year improvement of 30 basis points. While our tonnage declined in the soft freight environment, our world-class service culture drove above-market pricing growth and share gains with local customers,&#8221; Harik said in a statement.
&#8220;On the cost side, we reduced purchased transportation expense by 53% as we insourced linehaul miles to a record level. And we generated another gain in labor productivity, supported by our proprietary technology.&#8221; Harik continued, &#8220;We&#8217;re executing at a high level and consistently outperforming the industry, with a strategy that positions us to deliver long-term margin expansion and earnings growth,&#8221; he added.
Price Action: XPO shares are trading lower by 8.88% to $120.54 at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46760627/magnificent-seven-microsoft-meta-nvdia-earnings-sp500-market-cap">Magnificent Seven Now Worth Over $19 Trillion—And They Make Up 35% Of The S&amp;P 500</a></li>
</ul>
Image by Miguel Perfectti via Shutterstock

XPO Cuts Costs, Expands Margins Despite Freight Slowdown

<a href="https://truthsocial.com/@realDonaldTrump/114949055879790174">https://truthsocial.com/@realDonaldTrump/114949055879790174</a>

President Trump Posts Letter On Truth Social To GSK

American Vanguard shares are trading higher after the company reported better-than-expected Q2 financial results.

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/07/2025-07-31_08h07_43.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">AI Trade</h4>
Please <a href="https://thearorareport.com/stock-market-chart-analysis-microsoft-meta-earnings-ai-trade-msft-mc-07312025">click here </a>for an enlarged chart of Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>).
Note the following:
<ul class="wp-block-list">
<li>This article is about the big picture, not an individual stock.&nbsp; The chart of MSFT stock is being used to illustrate the point.</li>
<li>The chart shows Microsoft earnings release yesterday.</li>
<li>The chart shows the over 8% jump in MSFT stock on earnings release.</li>
<li>RSI on the chart shows MSFT stock is now overbought.&nbsp; Overbought stocks are susceptible to a pullback.</li>
<li>Microsoft earnings were the best in recent memory.</li>
<li>Meta Platforms Inc (META) also reported the best earnings in recent memory. </li>
<li>Here are the important implications for the AI trade of the stellar earnings from Microsoft and Meta: 
<ul class="wp-block-list">
<li>With continued spending on AI and infrastructure, these companies are transitioning from "asset-light" to "asset-heavy" companies.&nbsp; Becoming asset-heavy will make these companies more cyclical compared to the past.&nbsp; Being cyclical is fine as long as the economy is robust.&nbsp; However, in a recession, the pullback in these stocks will be much sharper compared to the past.&nbsp;&nbsp; 
<ul class="wp-block-list">
<li>This means investors, now more than ever, need to be adept at dynamic hedging and taking partial profits into strength.  </li>
</ul>
</li>
<li>Most investors are already familiar with the concepts of artificial intelligence and artificial general intelligence.&nbsp; There is a high probability that the concept of artificial super intelligence may take hold.</li>
<li>Traditionally,  Meta and Microsoft have spent about 15% &#8211; 20% of their revenues on capital expenditures.  Now, they are on track to spend about 30%.  In the short term, this is good for companies such as NVIDIA Corp (NVDA), Advanced Micro Devices Inc (AMD), Broadcom Inc (AVGO), Micron Technology Inc (MU), and Vertiv Holdings Co (VRT).  However, at some point, this spend will decline, exposing investors' positions in stocks like NVDA to a very large risk to the downside.  </li>
</ul>
</li>
<li>Amazon.com, Inc. (AMZN) and Apple Inc (AAPL) will report earnings today after the regular session close.</li>
<li>The U.S. economy is 70% consumer based.&nbsp; For this reason, prudent investors pay attention to personal income and personal spending.&nbsp; Personal spending dropped.&nbsp; This is inline with the other data of the consumer pulling back that we have been sharing with you.&nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Personal spending came at 0.3% vs. 0.4% consensus.</li>
<li>Personal income came at 0.3% vs. 0.3% consensus.</li>
</ul>
</li>
<li>We previously shared with you that economists have become good at predicting the Fed&#8217;s favorite inflation gauge PCE.&nbsp; PCE data came as expected.&nbsp; Here are the details: 
<ul class="wp-block-list">
<li>Headline PCE came at 0.3% vs. 0.3% consensus.</li>
<li>Core PCE came at 0.3% vs. 0.3% consensus.</li>
</ul>
</li>
<li>Initial jobless claims came at 218K vs. 220K consensus.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are positive in Amazon (AMZN), Meta (META), Microsoft (MSFT), NVIDIA Corp (NVDA), and Tesla Inc (TSLA).
In the early trade, money flows are neutral in Apple (AAPL) and Alphabet Inc Class C (GOOG).
In the early trade, money flows are positive in SPDR S&amp;P 500 ETF Trust (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin is range bound.
<h4 class="wp-block-heading">What To Do Now</h4>
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.

Equities

Opinion

MSFT

What Microsoft And Meta's Best Earnings In Recent Memory Mean For The AI Trade

<a href="https://truthsocial.com/@realDonaldTrump/114949054223938788">https://truthsocial.com/@realDonaldTrump/114949054223938788</a>

President Trump Posts Letter To Merck On Truth Social

TWNP

Twin Hospitality Group shares are trading lower after the company reported a year-over-year decrease in Q2 revenue results.

Baxter International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAX#NYSE">BAX</a>) is down 19.4% at $22.66 at the last check on Thursday. At around 11 a.m. EST, shares of the medical device company traded at $21.68—just shy of its 52-week low. 
Baxter reported a second-quarter adjusted EPS of 59 cents. That&#8217;s inline with the management guidance of 59-63 cents and the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">Wall Street estimate of 61 cents</a>.
Baxter reported sales of $2.81 billion, up 4% year over year on a reported basis and 1% on an operational basis. That&#8217;s almost in line with the <a href="https://www.benzinga.com/pressreleases/25/07/b46752003/baxter-reports-second-quarter-2025-results" target="_blank" rel="noreferrer noopener">consensus of $2.82 billion</a>.
Management expected second quarter sales growth of 4%-5% on a reported basis and 1%-2% on an operational basis.
Medical Products &amp; Therapies sales were flat year-over-year (+1% on a constant currency basis) at $1.32 billion.
Performance in the quarter reflected global strength for Advanced Surgery and infusion systems products within the Infusion Therapies &amp; Technologies division. The softness in demand for IV solutions, due to fluid conservation efforts enacted following Hurricane Helene, offset the segment's growth in the quarter.
Healthcare Systems &amp; Technologies sales for the second quarter totaled approximately $767 million, an increase of 3% on a reported and 2% on an operational basis.
Performance in the quarter reflected solid global growth for the Care &amp; Connectivity Solutions division, with notable improvements in international growth.
Sales in the Front Line Care division improved sequentially but declined compared to the prior year, driven by softness in select markets outside the U.S.
Pharmaceutical sales reached $612 million, an increase of 2% on a reported basis and 1% on an operational basis.
Positive performance in the quarter reflected strength in Drug Compounding, which was partially offset by reduced sales of Injectables &amp; Anesthesia.
Injectable sales declined 1%, primarily reflecting a difficult comparison to the prior-year period due to the timing of a government order. Anesthesia sales declined low double digits in the quarter globally. 
Guidance: Baxter lowered its 2025 adjusted earnings guidance from $2.47-$2.55 to&nbsp;$2.42-$2.52&nbsp;compared to the consensus of&nbsp;$2.52.
Baxter expects sales growth from continuing operations of 6%-7% on a reported basis, down from the <a target="_blank" href="https://www.benzinga.com/general/health-care/25/05/45142151/baxter-reports-strong-medical-devices-sales-in-q1-lifts-2025-guidance-stock-jumps" rel="noreferrer noopener">prior range of 7%-8%</a>. On an operational basis, Baxter expects sales growth of 3% to 4%, compared to 4%-5% expected previously.
For the third-quarter, Baxter expects sales growth from continuing operations of 6% to 7% on a reported basis. It also expects 3% to 4% on an operational basis.
The company expects adjusted earnings of 58 to 62 cents per share, below the consensus of 65&nbsp;cents.
Now Read:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46754175/microsoft-meta-stocks-add-440-billion-in-a-day-nearly-matching-netflixs-entire-503-billion-market-cap" target="_blank" rel="noreferrer noopener">Microsoft, Meta Stocks Add $440 Billion In A Day—Nearly Matching Netflix&#8217;s Entire $503 Billion Market Cap</a></li>
</ul>
Image: Shutterstock

Large Cap

Health Care

Hospital Product Maker Baxter Stock Plunges On Trimmed Annual Outlook

<a href="https://truthsocial.com/@realDonaldTrump/114949053111575171">https://truthsocial.com/@realDonaldTrump/114949053111575171</a>

REGN

President Trump Posts Letter To Regeneron Pharmaceuticals On Truth Social

SLXN

Silexion Therapeutics shares are trading higher after the company announced it's preparing a Phase 2/3 clinical trial for SIL204.

Economics

Press Releases

CarGurus Report Shows Automotive Affordability Continues to Drive the Market

CarGurus To Report First Quarter 2025 Financial Results

CarGurus to Present at the J.P. Morgan 53rd Annual Global Technology, Media and Communications Conference

CarGurus Announces First Quarter 2025 Results

CarGurus to Present at William Blair's 45th Annual Growth Stock Conference

CarGurus Launches AI-Powered Car Shopping Experience

CarGurus Report Finds Consumer Demand for Affordability and Fuel Efficiency Shaping Today's Auto Market

CarGurus Launches a Summer of Giveaways Alongside New 'Big Deal' Video Series Celebrating Life's Biggest Moments

CarGurus To Report Second Quarter 2025 Financial Results

AutoCanada Selects CarGurus as Preferred Partner Powering its Digital Marketing and Business Intelligence Strategy

CARG

TSX:ACQ

Autohome Inc. American Depositary Shares, each representing four class A ordinary shares.

Comments

CarGurus

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO